Cargando…
90-gene signature assay for tissue origin diagnosis of brain metastases
BACKGROUND: Brain metastases (BM) are the most common intracranial tumors. 2–14% of BM patients present with unknown primary site despite intensive evaluations. This study aims to evaluate the performance of a 90-gene expression signature in determining the primary sites for BM samples. METHODS: The...
Autores principales: | Zheng, Yulong, Ding, Yongfeng, Wang, Qifeng, Sun, Yifeng, Teng, Xiaodong, Gao, Qiqi, Zhong, Weixiang, Lou, Xiaofeng, Xiao, Cheng, Chen, Chengshu, Xu, Qinghua, Xu, Nong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771090/ https://www.ncbi.nlm.nih.gov/pubmed/31570099 http://dx.doi.org/10.1186/s12967-019-2082-1 |
Ejemplares similares
-
Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas
por: Wang, Qifeng, et al.
Publicado: (2017) -
Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study
por: Wang, Qifeng, et al.
Publicado: (2019) -
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy
por: Zheng, Yulong, et al.
Publicado: (2022) -
Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients
por: Sun, Wei, et al.
Publicado: (2022) -
Are 90% of deaths from cancer caused by metastases?
por: Dillekås, Hanna, et al.
Publicado: (2019)